Advertisement
Screener

BIO-TECHNE Corp (TECH) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

2.8 / 5 stars · 68/120 Roast Me

BIO-TECHNE Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

BIO-TECHNE Corp (TECH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 988.00 thousand shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-24

  • BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was -12.00K shares, a 110.62% decline year-over-year.
  • BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 100.00K shares.
  • BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
  • BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 900.00K shares, a 12.50% increase year-over-year.
  • BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2026 was 988.00K shares, a 8.21% increase from fiscal 2025.
  • BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 913.00K shares, a 13.87% decline from fiscal 2024.
  • BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.06M shares, a 54.91% decline from fiscal 2023.
  • BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.35M shares, a 69.14% increase from fiscal 2022.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed
2026-06-30-12.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24
88.00K shares
derived: sum of 2 quarters · filed 2026-08-24
88.00K shares
derived: sum of 3 quarters · filed 2026-08-24
988.00K shares
10-K · filed 2026-08-24
2026-03-31100.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06
100.00K shares
derived: sum of 2 quarters · filed 2026-05-06
1.00M shares
10-Q · filed 2026-05-06
1.11M shares
derived: sum of 4 quarters · filed 2026-08-24
2025-12-310.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04
900.00K shares
10-Q · filed 2026-02-04
1.01M shares
derived: sum of 3 quarters · filed 2026-08-24
1.01M shares
derived: sum of 4 quarters · filed 2026-08-24
2025-09-30900.00K shares
10-Q · filed 2025-11-05
1.01M shares
derived: sum of 2 quarters · filed 2026-08-24
1.01M shares
derived: sum of 3 quarters · filed 2026-08-24
1.01M shares
derived: sum of 4 quarters · filed 2026-08-24
2025-06-30113.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24
113.00K shares
derived: sum of 2 quarters · filed 2026-08-24
113.00K shares
derived: sum of 3 quarters · filed 2026-08-24
913.00K shares
10-K · filed 2026-08-24
2025-03-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06
0.00 shares
derived: sum of 2 quarters · filed 2026-05-06
800.00K shares
10-Q · filed 2026-05-06
860.00K shares
derived: sum of 4 quarters · filed 2026-08-24
2024-12-310.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04
800.00K shares
10-Q · filed 2026-02-04
860.00K shares
derived: sum of 3 quarters · filed 2026-08-24
960.00K shares
derived: sum of 4 quarters · filed 2026-08-24
2024-09-30800.00K shares
10-Q · filed 2025-11-05
860.00K shares
derived: sum of 2 quarters · filed 2026-08-24
960.00K shares
derived: sum of 3 quarters · filed 2026-08-24
1.06M shares
derived: sum of 4 quarters · filed 2026-08-24
2024-06-3060.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24
160.00K shares
derived: sum of 2 quarters · filed 2026-08-24
260.00K shares
derived: sum of 3 quarters · filed 2026-08-24
1.06M shares
10-K · filed 2026-08-24
2024-03-31100.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-08
200.00K shares
derived: sum of 2 quarters · filed 2025-05-08
1.00M shares
10-Q · filed 2025-05-08
1.05M shares
derived: sum of 4 quarters · filed 2025-08-22
2023-12-31100.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-06
900.00K shares
10-Q · filed 2025-02-06
951.00K shares
derived: sum of 3 quarters · filed 2025-08-22
951.00K shares
derived: sum of 4 quarters · filed 2025-08-22
2023-09-30800.00K shares
10-Q · filed 2024-11-05
851.00K shares
derived: sum of 2 quarters · filed 2025-08-22
851.00K shares
derived: sum of 3 quarters · filed 2025-08-22
851.00K shares
derived: sum of 4 quarters · filed 2025-08-22
2023-06-3051.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22
51.00K shares
derived: sum of 2 quarters · filed 2025-08-22
51.00K shares
derived: sum of 3 quarters · filed 2025-08-22
2.35M shares
10-K · filed 2025-08-22
2023-03-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-06
0.00 shares
derived: sum of 2 quarters · filed 2024-05-06
2.30M shares
10-Q · filed 2024-05-06
2.29M shares
derived: sum of 4 quarters · filed 2024-08-22
2022-12-310.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-07
2.30M shares
10-Q · filed 2024-02-07
2.29M shares
derived: sum of 3 quarters · filed 2024-08-22
2.39M shares
derived: sum of 4 quarters · filed 2024-08-22
2022-09-302.30M shares
10-Q · filed 2023-11-07
600.00K shares
10-Q · filed 2022-11-07
2.29M shares
derived: sum of 2 quarters · filed 2024-08-22
2.39M shares
derived: sum of 3 quarters · filed 2024-08-22
3.39M shares
derived: sum of 4 quarters · filed 2024-08-22
2022-06-30-10.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22
90.00K shares
derived: sum of 2 quarters · filed 2024-08-22
1.09M shares
derived: sum of 3 quarters · filed 2024-08-22
1.39M shares
10-K · filed 2024-08-22
348.00K shares
10-K · filed 2022-08-24
2022-03-31100.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-08
1.10M shares
derived: sum of 2 quarters · filed 2023-05-08
1.40M shares
10-Q · filed 2023-05-08
300.00K shares
10-Q · filed 2022-05-09
3.75M shares
derived: sum of 4 quarters · filed 2023-08-23
2021-12-311.00M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07
1.30M shares
10-Q · filed 2023-02-07
300.00K shares
10-Q · filed 2022-02-07
3.65M shares
derived: sum of 3 quarters · filed 2023-08-23
3.65M shares
derived: sum of 4 quarters · filed 2023-08-23
2021-09-30300.00K shares
10-Q · filed 2022-11-07
2.65M shares
derived: sum of 2 quarters · filed 2023-08-23
2.65M shares
derived: sum of 3 quarters · filed 2023-08-23
2.65M shares
derived: sum of 4 quarters · filed 2023-08-23
2021-06-302.35M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23
2.35M shares
derived: sum of 2 quarters · filed 2023-08-23
2.35M shares
derived: sum of 3 quarters · filed 2023-08-23
3.05M shares
10-K · filed 2023-08-23
763.00K shares
10-K · filed 2021-08-25
2021-03-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-09
0.00 shares
derived: sum of 2 quarters · filed 2022-05-09
700.00K shares
10-Q · filed 2022-05-09
652.00K shares
derived: sum of 4 quarters · filed 2022-08-24
2020-12-310.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-07
700.00K shares
10-Q · filed 2022-02-07
652.00K shares
derived: sum of 3 quarters · filed 2022-08-24
752.00K shares
derived: sum of 4 quarters · filed 2022-08-24
2020-09-30700.00K shares
10-Q · filed 2021-11-08
652.00K shares
derived: sum of 2 quarters · filed 2022-08-24
752.00K shares
derived: sum of 3 quarters · filed 2022-08-24
752.00K shares
derived: sum of 4 quarters · filed 2022-08-24
2020-06-30-48.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24
52.00K shares
derived: sum of 2 quarters · filed 2022-08-24
52.00K shares
derived: sum of 3 quarters · filed 2022-08-24
752.00K shares
10-K · filed 2022-08-24
2020-03-31100.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-07
100.00K shares
derived: sum of 2 quarters · filed 2021-05-07
800.00K shares
10-Q · filed 2021-05-07
817.00K shares
derived: sum of 4 quarters · filed 2021-08-25
2019-12-310.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08
700.00K shares
10-Q · filed 2021-02-08
717.00K shares
derived: sum of 3 quarters · filed 2021-08-25
717.00K shares
derived: sum of 4 quarters · filed 2021-08-25
2019-09-30700.00K shares
10-Q · filed 2020-11-09
717.00K shares
derived: sum of 2 quarters · filed 2021-08-25
717.00K shares
derived: sum of 3 quarters · filed 2021-08-25
717.00K shares
derived: sum of 4 quarters · filed 2021-08-25
2019-06-3017.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25
17.00K shares
derived: sum of 2 quarters · filed 2021-08-25
17.00K shares
derived: sum of 3 quarters · filed 2021-08-25
917.00K shares
10-K · filed 2021-08-25
2019-03-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11
0.00 shares
derived: sum of 2 quarters · filed 2020-05-11
900.00K shares
10-Q · filed 2020-05-11
887.00K shares
derived: sum of 4 quarters · filed 2020-08-26
2018-12-310.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06
900.00K shares
10-Q · filed 2020-02-06
887.00K shares
derived: sum of 3 quarters · filed 2020-08-26
987.00K shares
derived: sum of 4 quarters · filed 2020-08-26
2018-09-30900.00K shares
10-Q · filed 2019-11-06
887.00K shares
derived: sum of 2 quarters · filed 2020-08-26
987.00K shares
derived: sum of 3 quarters · filed 2020-08-26
1.39M shares
derived: sum of 4 quarters · filed 2020-08-26
2018-06-30-13.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26
87.00K shares
derived: sum of 2 quarters · filed 2020-08-26
487.00K shares
derived: sum of 3 quarters · filed 2020-08-26
1.09M shares
10-K · filed 2020-08-26
2018-03-31100.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07
500.00K shares
derived: sum of 2 quarters · filed 2019-05-07
1.10M shares
10-Q · filed 2019-05-07
1.14M shares
derived: sum of 4 quarters · filed 2019-11-06
2017-12-31400.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07
1.00M shares
10-Q · filed 2019-02-07
1.03M shares
derived: sum of 3 quarters · filed 2019-11-06
1.03M shares
derived: sum of 4 quarters · filed 2019-11-06
2017-09-30600.00K shares
10-Q · filed 2018-11-07
635.00K shares
derived: sum of 2 quarters · filed 2019-11-06
635.00K shares
derived: sum of 3 quarters · filed 2019-11-06
735.00K shares
derived: sum of 4 quarters · filed 2019-11-06
2017-06-3035.00K shares
derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06
35.00K shares
derived: sum of 2 quarters · filed 2019-11-06
135.00K shares
derived: sum of 3 quarters · filed 2019-11-06
1.14M shares
10-K/A · filed 2019-11-06
2017-03-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09
100.00K shares
derived: sum of 2 quarters · filed 2018-05-09
1.10M shares
10-Q · filed 2018-05-09
2016-12-31100.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08
1.10M shares
10-Q · filed 2018-02-08
2016-09-301.00M shares
10-Q · filed 2017-11-09
2016-03-3127.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10
68.00K shares
derived: sum of 2 quarters · filed 2017-05-10
804.00K shares
10-Q · filed 2017-05-10
2015-12-3141.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09
777.00K shares
10-Q · filed 2017-02-09
2015-09-30736.00K shares
10-Q · filed 2016-11-09
2015-03-31-26.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10
71.00K shares
derived: sum of 2 quarters · filed 2016-05-10
538.00K shares
10-Q · filed 2016-05-10
2014-12-3197.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09
564.00K shares
10-Q · filed 2016-02-09
529.00K shares
10-Q · filed 2015-02-09
2014-09-30467.00K shares
10-Q · filed 2015-11-09
2014-03-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11
32.00K shares
derived: sum of 2 quarters · filed 2015-05-11
167.00K shares
10-Q · filed 2015-05-11
2013-12-3132.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-09
167.00K shares
10-Q · filed 2015-02-09
2013-09-30135.00K shares
10-Q · filed 2014-11-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Twist Bioscience Corp (TWST)United States$11.540B-47.21
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78